← Open Payments lookup

LAURA OLSON: Open Payments

NPI 1255703799 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,080 in 146 payments from 28 companies in 2025. Trend: 2023 $415 · 2024 $2,377 · 2025 $3,080

Food & beverage: $3,080
CompanyPaymentsAmount
Novo Nordisk Inc23$458
Amgen Inc.21$312
Sequel Med Tech, LLC5$261
Tandem Diabetes Care, Inc.8$214
Lilly USA, LLC11$210
RECORDATI_RARE_DISEASES_INC.8$157
SANOFI-AVENTIS U.S. LLC9$156
Amneal Pharmaceuticals LLC13$151
Radius Health, Inc.5$124
Ascendis Pharma Endocrinology Inc4$108

Products named: Ozempic, TWIIST, t:slim X2 Insulin Pump with Control-IQ, TEPEZZA, Wegovy, ISTURISA, TZIELD, UNITHROID.

Industry payments across TX — which companies pay providers there.